Biosynthesis of a steroid metabolite by an engineered Rhodococcus erythropolis strain expressing a mutant cytochrome P450 BM3 enzyme.

Appl Microbiol Biotechnol

AIMMS-Division of Molecular Toxicology, Department of Chemistry and Pharmaceutical Sciences, Vrije Universiteit, De Boelelaan 1083, 1081 HV, Amsterdam, The Netherlands.

Published: June 2015

AI Article Synopsis

  • The study examines the ability of a Rhodococcus erythropolis mutant strain, RG9, to biotransform norandrostenedione using a cytochrome P450 BM3 mutant enzyme (M02).
  • The purified enzyme demonstrated over 95% regioselectivity in hydroxylating the steroid, producing 16-β-OH norandrostenedione, which was confirmed through NMR analysis.
  • Whole cells of RG9 achieved the conversion of norandrostenedione to the hydroxylated product without any activity from the strain alone, highlighting the potential of R. erythropolis for effective steroid bioconversions using this enzyme.

Article Abstract

In the present study, the use of Rhodococcus erythropolis mutant strain RG9 expressing the cytochrome P450 BM3 mutant M02 enzyme has been evaluated for whole-cell biotransformation of a 17-ketosteroid, norandrostenedione, as a model substrate. Purified P450 BM3 mutant M02 enzyme hydroxylated the steroid with >95 % regioselectivity to form 16-β-OH norandrostenedione, as confirmed by NMR analysis. Whole cells of R. erythropolis RG9 expressing P450 BM3 M02 enzyme also converted norandrostenedione into the 16-β-hydroxylated product, resulting in the formation of about 0.35 g/L. Whole cells of strain RG9 itself did not convert norandrostenedione, indicating that metabolite formation is P450 BM3 M02 enzyme mediated. This study shows that R. erythropolis is a novel and interesting host for the heterologous expression of highly selective and active P450 BM3 M02 enzyme variants able to perform steroid bioconversions.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00253-014-6281-7DOI Listing

Publication Analysis

Top Keywords

p450 bm3
24
m02 enzyme
20
bm3 m02
12
rhodococcus erythropolis
8
cytochrome p450
8
strain rg9
8
rg9 expressing
8
bm3 mutant
8
mutant m02
8
p450
6

Similar Publications

Production of derivatives of α-terpineol by bacterial CYP102A1 enzymes.

Biotechnol Lett

November 2024

School of Biological Sciences and Biotechnology, Graduate School, Chonnam National University, 77 Yongbongro, Gwangju, 61186, Republic of Korea.

The monooxygenase activity of engineered CYP102A1 on α-terpineol was investigated. CYP102A1 M850 mutant (F11Y/R47L/D68G/F81I/F87V/E143G/L188Q/E267V/H408R) showed the highest catalytic activity toward α-terpineol among the engineered mutants produced by random mutagenesis. The major product (P1) of α-terpineol, p-menth-1-ene-3,8-diol, was characterized by high-performance liquid chromatography, gas-chromatography mass spectrometry, and nuclear magnetic resonance spectroscopy.

View Article and Find Full Text PDF
Article Synopsis
  • * The process begins with engineering a biosynthetic pathway to produce drimenol, followed by the use of an engineered enzyme for a specific hydroxylation reaction.
  • * Finally, a nickel-catalyzed reductive coupling technique is employed to synthesize various drimane meroterpenoids in a streamlined and enantiospecific way, which could lead to further optimization of their biological activities.
View Article and Find Full Text PDF

Engineering Regioselectivity of P450 BM3 Enables the Biosynthesis of Murideoxycholic Acid by 6β-Hydroxylation of Lithocholic Acid.

Biotechnol J

November 2024

MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, P. R. China.

Murideoxycholic acid (MDCA), as a significant secondary bile acid derived from the metabolism of α/β-muricholic acid in rodents, is an important component in maintaining the bile acid homeostasis. However, the biosynthesis of MDCA remains a challenging task. Here, we present the development of cytochrome P450 monooxygenase CYP102A1 (P450 BM3) from Bacillus megaterium, employing semi-rational protein engineering technique.

View Article and Find Full Text PDF

(+)-3,6-Epoxymaaliane: A Novel Derivative of (+)-Bicyclogermacrene Oxidation Catalyzed by CYP450 BM3-139-3 and Its Variants.

Chembiochem

November 2024

State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 130 Meilong Road, Shanghai, 200237, China.

(+)-Bicyclogermacrene is a sesquiterpene compound found in various plant essential oils and serves as a crucial precursor for multiple biologically active compounds. Many derivatives of (+)-bicyclogermacrene have been shown to exhibit valuable bioactivities. Cytochrome P450 BM3 from Bacillus megaterium can catalyze a variety of substrates and different types of oxidation reactions, making it become a powerful tool for oxidizing terpenes.

View Article and Find Full Text PDF
Article Synopsis
  • Experimental methods in single-molecule enzymology enable scientists to analyze the unique properties and function of individual enzyme molecules during their catalytic processes.
  • The study utilizes solid-state nanopores, specifically a 5 nm pore in a silicon nitride chip, to observe the performance of cytochrome P450 BM3, a model enzyme in monooxygenase systems.
  • By measuring ion current changes while the enzyme catalyzes laurate hydroxylation, the research showed that the BM3 enzyme is active for up to 1500 seconds, with potential applications in developing sensitive detectors for enzyme studies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!